Published in Immunology on June 01, 1992
Correlates of protection induced by vaccination. Clin Vaccine Immunol (2010) 5.21
Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol (1997) 1.45
Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J Virol (1994) 1.43
Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol (1995) 1.40
CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability. J Exp Med (2000) 1.29
Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance. J Virol (2007) 0.94
CD4+ T cells are essential in overcoming experimental murine measles encephalitis. Immunology (1994) 0.93
Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity. J Clin Microbiol (1998) 0.90
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model. Retrovirology (2011) 0.89
A comparison of the immune responses of dogs exposed to canine distemper virus (CDV) - Differences between vaccinated and wild-type virus exposed dogs. Can J Vet Res (2010) 0.78
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med (1991) 4.49
T-lymphocyte entry into the central nervous system. J Neurosci Res (1991) 4.28
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol (1987) 3.16
Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol (1984) 2.21
HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol (1989) 2.11
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol (1990) 1.99
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci U S A (1988) 1.43
Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc Natl Acad Sci U S A (1986) 1.38
Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J Virol (1990) 1.36
Measles virus nucleocapsid protein protects rats from encephalitis. J Virol (1991) 1.33
Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats. J Gen Virol (1987) 1.26
Purification, morphology and antigenic characterization of measles virus envelope components. J Gen Virol (1984) 1.16
Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J Immunol (1991) 1.15
Measles control: so near and yet so far. Prog Med Virol (1985) 1.14
Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol (1988) 1.04
Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats. J Neuroimmunol (1988) 0.97
Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. J Gen Virol (1991) 0.94
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A (1991) 4.07
The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol (1982) 3.12
Genomic RNA of the murine coronavirus JHM. J Gen Virol (1978) 2.78
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Coronavirus JHM: cell-free synthesis of structural protein p60. J Virol (1980) 2.37
The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A (1991) 2.23
Coronavirus JHM: intracellular protein synthesis. J Gen Virol (1981) 2.05
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology (2000) 2.02
Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol (1997) 2.00
CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol (2001) 1.94
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology (1989) 1.82
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol (2000) 1.74
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
Infectious DNA of the human spumaretrovirus. Nucleic Acids Res (1990) 1.67
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Temporal and geographical distribution of measles virus genotypes. J Gen Virol (1995) 1.61
Comparison of subacute sclerosing panencephalitis and measles viruses: an electron microscope study. J Virol (1971) 1.61
Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol (1990) 1.60
Differential downregulation of CD46 by measles virus strains. J Virol (1995) 1.57
Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet (1972) 1.55
Altered ratios of measles virus transcripts in diseased human brains. Virology (1987) 1.55
Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique. J Gen Virol (1983) 1.50
Membrane proteins of subacute sclerosing panencephalitis and measles viruses. Nature (1978) 1.49
Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J Virol (1985) 1.48
Physical association of moesin and CD46 as a receptor complex for measles virus. J Virol (1995) 1.48
Viral particles induce Ia antigen expression on astrocytes. Nature (1986) 1.46
Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol (1997) 1.45
Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology (1994) 1.44
Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J Virol (1994) 1.43
MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol (1993) 1.43
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Clonal expansion of hypermutated measles virus in a SSPE brain. Virology (1993) 1.42
Subacute sclerosing panencephalitis: a review. Curr Top Microbiol Immunol (1972) 1.41
The structure and replication of coronaviruses. Curr Top Microbiol Immunol (1982) 1.40
Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol (1995) 1.40
Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci (1994) 1.39
Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology (1992) 1.39
The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol (1999) 1.38
Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med (2001) 1.38
Structural polypeptides of the murine coronavirus JHM. J Gen Virol (1979) 1.37
Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature (1983) 1.36
Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J Virol (1990) 1.36
Identification of several different lineages of measles virus. J Gen Virol (1991) 1.35
Isolation of infectious measles virus in measles encephalitis. Lancet (1972) 1.35
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
Measles virus nucleocapsid protein protects rats from encephalitis. J Virol (1991) 1.33
Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathol (1978) 1.32
Morphogenesis and structure of a virus in cells cultured from brain tissue from two cases of multiple sclerosis. Lab Invest (1973) 1.31
Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology (1990) 1.30
Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol (1986) 1.27
Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization. J Gen Virol (1979) 1.27
Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats. J Gen Virol (1987) 1.26
Demonstration of HLA restricted killer cells in patients with acute measles. Med Microbiol Immunol (1979) 1.26
CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol (1997) 1.26
Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol (1995) 1.25
Measles virus induced immunosuppression: targets and effector mechanisms. Curr Mol Med (2001) 1.25
A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol (1999) 1.25
Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature (1983) 1.25
Progressive multifocal leucoencephalopathy: detection of papovavirus JC in kidney tissue. J Med Virol (1983) 1.24
Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE. J Immunol (1975) 1.22
Measles virus gene expression in subacute sclerosing panencephalitis. Virus Res (1984) 1.22
Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J Virol (1996) 1.19
Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci U S A (1987) 1.18
Electron microscopic observations in subacute sclerosing panencephalitis brain cell cultures: their correlation with cytochemical and immunocytological findings. J Virol (1970) 1.17
Measles virus persistency and disease. Prog Med Virol (1984) 1.16
Multiple sclerosis and parainfluenza 1 virus. History of the isolation of the virus and expression of phenotypic differences between the isolated virus and Sendai virus. J Neurol (1975) 1.15
Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion. J Virol (2000) 1.14
Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol (1992) 1.14
Dendritic cells and measles virus infection. Curr Top Microbiol Immunol (2003) 1.14
Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J Virol (1999) 1.14
Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology (1989) 1.13
Differential receptor usage by measles virus strains. J Gen Virol (1998) 1.13
RD cells in the laboratory diagnosis of enteroviruses. Med Microbiol Immunol (1977) 1.13
Demyelinating encephalomyelitis induced by a long-term corona virus infection in rats. A preliminary report. Acta Neuropathol (1979) 1.12
RNA-dependent RNA polymerase activity in murine coronavirus-infected cells. J Gen Virol (1983) 1.12
Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J Virol (1993) 1.12
A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol (2000) 1.10
Adaptation of coronavirus JHM to persistent infection of murine sac(-) cells. J Gen Virol (1984) 1.10